Status:
COMPLETED
Exclusion of Intra-atrial Thrombus Before Catheter Ablation
Lead Sponsor:
Groupe Hospitalier de la Rochelle Ré Aunis
Collaborating Sponsors:
Diagnostica Stago
Conditions:
Atrial Fibrillation
Thrombi
Eligibility:
All Genders
18+ years
Brief Summary
Atrial fibrillation is the most frequent heart rhythm disorder. Its symptomatic forms, resistant to drug therapy, require invasive management (catheter ablation), which exposes to potentially serious ...
Eligibility Criteria
Inclusion
- Adult patients,
- Patients hospitalized for ablation of atrial fibrillation or symptomatic left atrial tachycardia,
- have signed or orally given an informed consent
Exclusion
- Contraindication to transoesophageal echocardiography,
- Transoesophageal echocardiography made in another centre than the centre of ablation,
- Pregnant women, parturient mothers and nursing mothers,
- Lives in an institution on court or authority order,
- Severely altered psychological health,
- Persons leaving in health or social establishment,
- Minors,
- Under guardianship,
- Persons unable to give their consent,
- Refusal to participate in the study.
Key Trial Info
Start Date :
September 18 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 7 2020
Estimated Enrollment :
3160 Patients enrolled
Trial Details
Trial ID
NCT03455673
Start Date
September 18 2018
End Date
November 7 2020
Last Update
December 22 2023
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de cardiologie, Centre Hospitalier du pays d'Aix
Aix-en-Provence, France
2
Service de cardiologie, CH Annecy Genevois
Annecy, France
3
Service de cardiologie, CHU Brest
Brest, France
4
Groupe Hospitalier de la Rochelle Ré Aunis
La Rochelle, France